stella
beta
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding — Stella
Recruiting
Back to Fabry Disease trials
Trial locations
(5 sites)
United States
No physical study sites - Decentralized, web-based registry, Washington D.C., District of Columbia
Germany
No physical study sites - Decentralized, web-based registry, Berlin
Italy
No physical study sites - Decentralized, web-based registry, Rome
Spain
No physical study sites - Decentralized, web-based registry, Madrid
United Kingdom
No physical study sites - Decentralized, web-based registry, London
View full record on ClinicalTrials.gov